Compare IDEXX Laboratories, Inc. (IDXX) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Shopify Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Shopify Inc. trades at $170.85 (market cap $211.73B). The key difference: Shopify Inc. is far larger — about 5.2× IDEXX Laboratories, Inc.'s market cap, and Shopify Inc. is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Shopify Inc. for 78 Days on average.
| IDXX | SHOP | |
|---|---|---|
Market Cap | $40.43B | $211.73B |
Volume | 692,164 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $766.68 | $179.01 |
52-Week Low | $504.70 | $95.40 |
Typical Hold Time | 46 Days | 78 Days |
Enterprise Value | $41.32B | $206.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Shopify trades at $164.54, down 0.84% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust revenue growth, increasing from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 111.19. Recent developments include the launch of Canvas AI store builder and strategic moves in AI-powered commerce positioning.
Outlook remains positive with 67% analyst buy ratings and $168.63 consensus target, though high valuation and competitive pressures from Amazon present risks. Operating cash flow growth to $2.4B projected for 2026 supports continued investment in merchant solutions and AI capabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
